Literature DB >> 2308898

Quantitation of the relative amounts of anhydrous carbamazepine (C15H12N2O) and carbamazepine dihydrate (C15H12N2O.2H2O) in a mixture by solid-state nuclear magnetic resonance (NMR).

R Suryanarayanan1, T S Wiedmann.   

Abstract

The application of solid state nuclear magnetic resonance (NMR) for the quantitation of the relative amounts of carbamazepine anhydrate (I) and carbamazepine dihydrate (II) in a mixture is presented. The techniques of cross polarization, dipolar decoupling, and magic angle spinning have been used to obtain high-resolution NMR spectra of the samples in the solid state. Although the chemical shifts of I and II were similar, the proton spin lattice relaxation time of II was much shorter than that of I. A delay time of 10 sec between pulses resulted in saturation of the signal from I and in a spectrum arising solely from II. The dependence of the observed signal intensity on the contact time was evaluated for II and glycine, the internal standard, to allow theoretical estimation of the peak area ratios. Various molar ratios of I and II were then mixed with glycine, and the resulting peak area ratios of II to the area of the alpha and the carbonyl carbons of glycine was linearly related to the relative proportion of II in the mixture.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308898     DOI: 10.1023/a:1015889021145

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Characterization of habits and crystalline modification of solids and their pharmaceutical applications.

Authors:  J K Haleblian
Journal:  J Pharm Sci       Date:  1975-08       Impact factor: 3.534

2.  REPORT ON THE ANTI-EPILEPTIC ACTION OF TEGRETOL.

Authors:  J W JONGMANS
Journal:  Epilepsia       Date:  1964-03       Impact factor: 5.864

3.  DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS.

Authors:  E SHEFTER; T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-08       Impact factor: 3.534

4.  Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883).

Authors:  S BLOM
Journal:  Lancet       Date:  1962-04-21       Impact factor: 79.321

5.  [Hygroscopicity of carbamazepine crystalline powders].

Authors:  N Kaneniwa; T Yamaguchi; N Watari; M Otsuka
Journal:  Yakugaku Zasshi       Date:  1984-02       Impact factor: 0.302

6.  Solid state nuclear magnetic resonance of lipid bilayers.

Authors:  R G Griffin
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Thermodynamics of mercaptopurine dehydration.

Authors:  S Niazi
Journal:  J Pharm Sci       Date:  1978-04       Impact factor: 3.534

8.  Stability of extemporaneous suspensions of carbamazepine.

Authors:  G J Burckart; R W Hammond; M J Akers
Journal:  Am J Hosp Pharm       Date:  1981-12

9.  Determination of the relative amounts of anhydrous carbamazepine (C15H12N2O) and carbamazepine dihydrate (C15H12N2O.2H2O) in a mixture by powder x-ray diffractometry.

Authors:  R Suryanarayanan
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

10.  Analysis of solid-state Carbon-13 NMR spectra of polymorphs (benoxaprofen and nabilone) and pseudopolymorphs (cefazolin).

Authors:  S R Byrn; G Gray; R R Pfeiffer; J Frye
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

  10 in total
  4 in total

1.  Determination of the composition of delavirdine mesylate polymorph and pseudopolymorph mixtures using 13C CP/MAS NMR.

Authors:  P Gao
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

2.  Solid-state nuclear magnetic resonance (NMR) spectra of pharmaceutical dosage forms.

Authors:  P J Saindon; N S Cauchon; P A Sutton; C J Chang; G E Peck; S R Byrn
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

Review 3.  Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications.

Authors:  D E Bugay
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

4.  Solid-state emulsions: evaluation by 1H and 13C solid-state nuclear magnetic resonance.

Authors:  M L Shively; S F Dec
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.